Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Blackledge

Showing results (41-50 of 100) with videos related to

Pageof 10
Sort By:
Gynecologic Oncology|March 1, 1991
Short-duration (three cycles) cisplatin combination chemotherapy with alkylating agent consolidation in advanced epithelial ovarian cancerF G Lawton, C Hilton, J J Mould, et al.
Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality|June 6, 2006
Patient safety in emergency situations: A web-based pediatric arrest medication calculatorCharles G Blackledge, Michael A Veltri, Carol Matlin, et al.
Cancer Treatment Reports|June 1, 1987
Phase II study of mitoxantrone in epithelial ovarian cancerF Lawton, G Blackledge, J Mould, et al.
Cancer|September 15, 1983
The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's diseaseE Whitehead, S M Shalet, G Blackledge, et al.
Cancer|February 1, 1982
The effects of Hodgkin's disease and combination chemotherapy on gonadal function in the adult maleE Whitehead, S M Shalet, G Blackledge, et al.
Obstetrics and Gynecology|January 1, 1989
Neoadjuvant (cytoreductive) chemotherapy combined with intervention debulking surgery in advanced, unresected epithelial ovarian cancerF G Lawton, C W Redman, D M Luesley, et al.
British Journal of Cancer|October 1, 1992
Single agent high-dose cisplatin (200 mg m-2) treatment in ovarian carcinomaS Kehoe, C Redman, R Varma, et al.
British Journal of Obstetrics and Gynaecology|January 1, 1989
Problems of peritoneal access in intraperitoneal treatment and monitoring of ovarian cancerC W Redman, F G Lawton, D M Luesley, et al.
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|July 28, 2007
A descriptive study of morbidity and mortality conferences and their conformity to medical incident analysis models: results of the morbidity and mortality conference improvement study, phase 1Hanan J Aboumatar, Charles G Blackledge, Conan Dickson, et al.
Investigational New Drugs|January 1, 1985
Phase II study of vincristine, mitomycin-C and mitoxantrone in advanced breast cancer: a preliminary report of response and toxicityT J Perren, G Blackledge, J J Mould, et al.
Pageof 10

Showing results (41-50 of 100) with videos related to

Sort By:
Pageof 10
Gynecologic Oncology|March 1, 1991
Short-duration (three cycles) cisplatin combination chemotherapy with alkylating agent consolidation in advanced epithelial ovarian cancerF G Lawton, C Hilton, J J Mould, et al.
Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality|June 6, 2006
Patient safety in emergency situations: A web-based pediatric arrest medication calculatorCharles G Blackledge, Michael A Veltri, Carol Matlin, et al.
Cancer Treatment Reports|June 1, 1987
Phase II study of mitoxantrone in epithelial ovarian cancerF Lawton, G Blackledge, J Mould, et al.
Cancer|September 15, 1983
The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's diseaseE Whitehead, S M Shalet, G Blackledge, et al.
Cancer|February 1, 1982
The effects of Hodgkin's disease and combination chemotherapy on gonadal function in the adult maleE Whitehead, S M Shalet, G Blackledge, et al.
Obstetrics and Gynecology|January 1, 1989
Neoadjuvant (cytoreductive) chemotherapy combined with intervention debulking surgery in advanced, unresected epithelial ovarian cancerF G Lawton, C W Redman, D M Luesley, et al.
British Journal of Cancer|October 1, 1992
Single agent high-dose cisplatin (200 mg m-2) treatment in ovarian carcinomaS Kehoe, C Redman, R Varma, et al.
British Journal of Obstetrics and Gynaecology|January 1, 1989
Problems of peritoneal access in intraperitoneal treatment and monitoring of ovarian cancerC W Redman, F G Lawton, D M Luesley, et al.
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|July 28, 2007
A descriptive study of morbidity and mortality conferences and their conformity to medical incident analysis models: results of the morbidity and mortality conference improvement study, phase 1Hanan J Aboumatar, Charles G Blackledge, Conan Dickson, et al.
Investigational New Drugs|January 1, 1985
Phase II study of vincristine, mitomycin-C and mitoxantrone in advanced breast cancer: a preliminary report of response and toxicityT J Perren, G Blackledge, J J Mould, et al.
Pageof 10